Payment overview · 2025
General Payments
$26.82
1 reported records · 1 companies
Healthcare provider profile · identity verified
Thoi Hue Lien, M.D.
Allopathic & Osteopathic Physicians|Family Medicine · ROSEMEAD, CA · NPI 1871653816
Verified facts
What the public records show
CMS Open Payments records show Thoi Hue Lien, M.D. received $26.82 in general payments during 2025 across 1 reported records.
Bayer Healthcare Pharmaceuticals Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
A separate comparison found the same explicitly named product in public Medicare Part D data: Kerendia.
Bayer Healthcare Pharmaceuticals Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Kerendia as an associated drug or biological on 138674 records involving 48458 distinct recipient NPIs. Public Medicare Part D data also shows 194 claims for Kerendia by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | Unresolved — no canonical attribution shown | $26.82 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $26.82 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Kerendia Normalized: kerendia |
Drug | Bayer Healthcare Pharmaceuticals Inc. | $26.82 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| Kerendia kerendia |
2025 | Kerendia | 2024 | 194 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. Exact reporting entity; no affiliate inference |
2025 | Kerendia open payments reported associated product |
CMS Open Payments — General Payments 138674 supporting records · 48458 recipient NPIs · example record 1225434663 |
Kerendia · 2024 Exact normalized brand match · 1 Part D row |
194 | 31 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 2314 | 366 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 1503 | 324 |
| Losartan Potassium | Losartan Potassium | 1373 | 221 |
| Celecoxib | Celecoxib | 1287 | 267 |
| Amlodipine Besylate | Amlodipine Besylate | 1262 | 196 |
| Metformin Hcl | Metformin Hcl | 1213 | 187 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 1107 | 173 |
| Alendronate Sodium | Alendronate Sodium | 1063 | 178 |
| Pantoprazole Sodium | Pantoprazole Sodium | 939 | 193 |
| Metoprolol Succinate | Metoprolol Succinate | 937 | 134 |
| Simvastatin | Simvastatin | 825 | 123 |
| Fluocinonide | Fluocinonide | 790 | 210 |
| Diclofenac Sodium | Diclofenac Sodium | 727 | 196 |
| Gabapentin | Gabapentin | 653 | 114 |
| Tamsulosin Hcl | Tamsulosin Hcl | 565 | 99 |
| Atenolol | Atenolol | 560 | 86 |
| Glipizide | Glipizide | 559 | 87 |
| Fluticasone Propionate | Fluticasone Propionate | 479 | 105 |
| Jardiance | Empagliflozin | 473 | 67 |
| Amoxicillin | Amoxicillin | 419 | 259 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 399 | 89 |
| Famotidine | Famotidine | 387 | 69 |
| Omeprazole | Omeprazole | 376 | 71 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 345 | 66 |
| Azelastine Hcl | Azelastine Hcl | 339 | 50 |
| Hydrochlorothiazide | Hydrochlorothiazide | 338 | 53 |
| Meloxicam | Meloxicam | 308 | 68 |
| Glimepiride | Glimepiride | 302 | 42 |
| Alcohol Prep Pads | Alcohol Antiseptic Pads | 288 | 117 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 281 | 47 |
| Diflorasone Diacetate | Diflorasone Diacetate | 267 | 132 |
| Meclizine Hcl | Meclizine Hcl | 261 | 113 |
| Januvia | Sitagliptin Phosphate | 258 | 34 |
| Azithromycin | Azithromycin | 233 | 161 |
| Benazepril Hcl | Benazepril Hcl | 232 | 30 |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 229 | 156 |
| Hydrocortisone | Hydrocortisone | 227 | 52 |
| Glipizide-Metformin | Glipizide/Metformin Hcl | 212 | 27 |
| Clopidogrel | Clopidogrel Bisulfate | 198 | 30 |
| Raloxifene Hcl | Raloxifene Hcl | 196 | 41 |
| Kerendia | Finerenone | 194 | 31 |
| Levothyroxine Sodium | Levothyroxine Sodium | 188 | 30 |
| Montelukast Sodium | Montelukast Sodium | 182 | 27 |
| Tramadol Hcl | Tramadol Hcl | 181 | 103 |
| Lisinopril | Lisinopril | 177 | 31 |
| Cyclosporine | Cyclosporine | 172 | 41 |
| Ketoconazole | Ketoconazole | 164 | 30 |
| Allopurinol | Allopurinol | 158 | 26 |
| Finasteride | Finasteride | 154 | 28 |
| Levofloxacin | Levofloxacin | 154 | 121 |
| Ibuprofen | Ibuprofen | 149 | 60 |
| Prednisone | Prednisone | 147 | 101 |
| Gemfibrozil | Gemfibrozil | 146 | 23 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 145 | 42 |
| Vascepa | Icosapent Ethyl | 145 | 27 |
| Temazepam | Temazepam | 143 | 51 |
| Licart | Diclofenac Epolamine | 139 | 45 |
| Donepezil Hcl | Donepezil Hcl | 137 | 21 |
| Furosemide | Furosemide | 136 | 32 |
| Lidocaine | Lidocaine | 134 | 23 |
| Procto-Med Hc | Hydrocortisone | 134 | 28 |
| Ventolin Hfa | Albuterol Sulfate | 132 | 20 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 131 | 25 |
| Terazosin Hcl | Terazosin Hcl | 128 | 21 |
| Sildenafil Citrate | Sildenafil Citrate | 123 | 27 |
| Pioglitazone Hcl | Pioglitazone Hcl | 119 | 15 |
| Ibandronate Sodium | Ibandronate Sodium | 115 | 21 |
| Fenofibrate | Fenofibrate Nanocrystallized | 114 | 15 |
| Carvedilol | Carvedilol | 111 | 19 |
| Potassium Chloride | Potassium Chloride | 111 | 26 |
| Clobetasol Propionate | Clobetasol Propionate | 109 | 22 |
| Ezetimibe | Ezetimibe | 103 | 15 |
| Acarbose | Acarbose | 100 | 17 |
| Zolpidem Tartrate | Zolpidem Tartrate | 99 | 35 |
| Nifedipine Er | Nifedipine | 97 | 16 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 94 | 20 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 94 | 19 |
| Icosapent Ethyl | Icosapent Ethyl | 92 | 20 |
| Betamethasone Dipropionate | Betamethasone Dipropionate | 91 | 19 |
| Omeprazole-Sodium Bicarbonate | Omeprazole/Sodium Bicarbonate | 91 | 21 |
| Lovastatin | Lovastatin | 90 | 13 |
| Naproxen-Esomeprazole Mag | Naproxen/Esomeprazole Mag | 90 | 38 |
| Pravastatin Sodium | Pravastatin Sodium | 90 | 14 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 89 | 38 |
| Linzess | Linaclotide | 88 | 21 |
| Doxazosin Mesylate | Doxazosin Mesylate | 87 | 18 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 83 | 14 |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 78 | 17 |
| Memantine Hcl | Memantine Hcl | 76 | 15 |
| Paroxetine Hcl | Paroxetine Hcl | 75 | 11 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 74 | 59 |
| Silver Sulfadiazine | Silver Sulfadiazine | 73 | 23 |
| Baclofen | Baclofen | 69 | suppressed |
| Ammonium Lactate | Ammonium Lactate | 65 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 63 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 62 | 50 |
| Dicyclomine Hcl | Dicyclomine Hcl | 62 | 19 |
| Nystatin | Nystatin | 62 | 16 |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 62 | 16 |
| Sucralfate | Sucralfate | 61 | 23 |
| Fenofibrate | Fenofibrate | 59 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 59 | suppressed |
| Lansoprazole | Lansoprazole | 58 | 11 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 58 | 40 |
| Clonazepam | Clonazepam | 56 | 12 |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 54 | suppressed |
| Xarelto | Rivaroxaban | 54 | suppressed |
| Dutasteride | Dutasteride | 53 | suppressed |
| Diclofenac Epolamine | Diclofenac Epolamine | 52 | 25 |
| Glyburide-Metformin Hcl | Glyburide/Metformin Hcl | 52 | 12 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 50 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 50 | suppressed |
| Benzonatate | Benzonatate | 48 | 29 |
| Mupirocin | Mupirocin | 47 | 32 |
| Hydralazine Hcl | Hydralazine Hcl | 45 | suppressed |
| Risperidone | Risperidone | 45 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 44 | suppressed |
| Methimazole | Methimazole | 44 | suppressed |
| Naproxen | Naproxen | 44 | 11 |
| Amitriptyline Hcl | Amitriptyline Hcl | 43 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 40 | suppressed |
| Prolia | Denosumab | 40 | 29 |
| Tenofovir Disoproxil Fumarate | Tenofovir Disoproxil Fumarate | 40 | suppressed |
| Valsartan | Valsartan | 39 | suppressed |
| Tradjenta | Linagliptin | 38 | suppressed |
| Clotrimazole | Clotrimazole | 37 | 12 |
| Megestrol Acetate | Megestrol Acetate | 37 | 16 |
| Lactulose | Lactulose | 36 | 11 |
| Lorazepam | Lorazepam | 36 | 11 |
| Nortriptyline Hcl | Nortriptyline Hcl | 36 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 35 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 34 | suppressed |
| Cephalexin | Cephalexin | 34 | 24 |
| Mometasone Furoate | Mometasone Furoate | 34 | 12 |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 34 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 33 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 33 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 33 | suppressed |
| Loperamide | Loperamide Hcl | 33 | 15 |
| Acyclovir | Acyclovir | 32 | 25 |
| Metoclopramide Hcl | Metoclopramide Hcl | 32 | 11 |
| Myrbetriq | Mirabegron | 32 | suppressed |
| Spironolactone | Spironolactone | 31 | suppressed |
| Entecavir | Entecavir | 30 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 30 | suppressed |
| Naproxen Sodium | Naproxen Sodium | 29 | suppressed |
| Nexium | Esomeprazole Magnesium | 29 | suppressed |
| Pregabalin | Pregabalin | 29 | suppressed |
| Trazodone Hcl | Trazodone Hcl | 29 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 28 | 13 |
| Clonidine Hcl | Clonidine Hcl | 28 | 11 |
| Farxiga | Dapagliflozin Propanediol | 28 | 11 |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 27 | suppressed |
| Restasis | Cyclosporine | 27 | 13 |
| Memantine Hcl Er | Memantine Hcl | 26 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 26 | 26 |
| Amlodipine-Valsartan | Amlodipine Besylate/Valsartan | 25 | suppressed |
| Invokana | Canagliflozin | 25 | suppressed |
| Nitroglycerin | Nitroglycerin | 24 | 11 |
| Betamethasone Diprop Augmented | Betamethasone/Propylene Glyc | 23 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 23 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 23 | 20 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 22 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 22 | suppressed |
| Sulfasalazine | Sulfasalazine | 22 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 21 | 17 |
| Easy Touch Alcohol Prep Pads | Alcohol Antiseptic Pads | 21 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 21 | suppressed |
| Ztlido | Lidocaine | 21 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 20 | suppressed |
| Naftifine Hcl | Naftifine Hcl | 20 | suppressed |
| Oseltamivir Phosphate | Oseltamivir Phosphate | 20 | 15 |
| Ciclopirox | Ciclopirox Olamine | 19 | suppressed |
| Clindamycin Phosphate | Clindamycin Phosphate | 19 | suppressed |
| Glipizide Er | Glipizide | 19 | suppressed |
| Janumet Xr | Sitagliptin Phos/Metformin Hcl | 19 | suppressed |
| Olanzapine | Olanzapine | 19 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 18 | suppressed |
| Novolin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 18 | suppressed |
| Bethanechol Chloride | Bethanechol Chloride | 17 | suppressed |
| Duloxetine Hcl | Duloxetine Hcl | 17 | suppressed |
| Eliquis | Apixaban | 17 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 17 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 17 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 16 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 16 | suppressed |
| Verapamil Er | Verapamil Hcl | 16 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 15 | suppressed |
| Isosorbide Mononitrate | Isosorbide Mononitrate | 15 | suppressed |
| Triazolam | Triazolam | 15 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 15 | suppressed |
| Fluticasone Propionate Hfa | Fluticasone Propionate | 14 | suppressed |
| Novolin 70-30 Flexpen | Insulin Nph Hum/Reg Insulin Hm | 14 | suppressed |
| Paxlovid (Eua) | Nirmatrelvir/Ritonavir | 14 | 14 |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 14 | suppressed |
| Semglee (Yfgn) Pen | Insulin Glargine-Yfgn | 14 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 14 | suppressed |
| Alcohol Swabs | Alcohol Antiseptic Pads | 13 | suppressed |
| Comfort Ez Pen Needle | Pen Needle, Diabetic | 13 | suppressed |
| Repaglinide | Repaglinide | 13 | suppressed |
| Scopolamine | Scopolamine | 13 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 13 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 13 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 12 | suppressed |
| Jentadueto | Linagliptin/Metformin Hcl | 12 | suppressed |
| Nystatin-Triamcinolone | Nystatin/Triamcinolone Acet | 12 | suppressed |
| Ranolazine Er | Ranolazine | 12 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 12 | suppressed |
| Zenpep | Lipase/Protease/Amylase | 12 | suppressed |
| Ciclopirox | Ciclopirox | 11 | suppressed |
| Polymyxin B Sul-Trimethoprim | Polymyxin B Sulf/Trimethoprim | 11 | 11 |
| Propylthiouracil | Propylthiouracil | 11 | suppressed |
| Ssd | Silver Sulfadiazine | 11 | suppressed |
| Tadalafil | Tadalafil | 11 | suppressed |
| Tolterodine Tartrate | Tolterodine Tartrate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $26.82 · 1 records | Bayer Healthcare Pharmaceuticals Inc. | Kerendia | 1 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Kerendia play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with Bayer Healthcare Pharmaceuticals Inc.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error